10x Genomics
TXG
$45.44
Share price
-2.30%
Change (1 day)
7.17%
Change (1 year)
Categories
10x Genomics (TXG) - Total debt
Total debt on the balance sheet as of June 2023 : $99.61 M
According to 10x Genomics 's latest financial reports the company's total debt is $99.61 M. A company’s total debt is the sum of all current and non-current debts.
10x Genomics - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $95.17 M | 16.1% |
| 2021-12-31 | $81.97 M | 30.17% |
| 2020-12-31 | $62.97 M | 111.91% |
| 2019-12-31 | $29.71 M | 0.14% |
| 2018-12-31 | $29.67 M | 181.05% |
| 2017-12-31 | $10.55 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $1.7 M | -98.29% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $50.51 M | -49.29% | 🇬🇧 UK |
 Novavax NVAX | $0.19 B | 99.71% | 🇺🇸 USA |
 Novocure
NVCR | $0.58 B | 489.74% | Jersey |